| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.04 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |